Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Butylphthalide for vascular dementia cerebral perfusion and cognition
ChiCTR2200056012Phase 4Recruiting
- Sponsor
- Tianjin First Central Hospital
- Start
- Dec 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of butylphthalide in vascular dementia (2 arms), sponsored by Tianjin First Central Hospital. Primary endpoint: Vascular dementia assessment scale-cog. Started Dec 2021; status: recruiting.
02
Drugs
butylphthalide
03
Conditions
vascular dementia
Beyond the preview
Go deeper on ChiCTR2200056012.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200056012.